Smargiasso Nicolas N

Show results for

Proteomics (3)

Organisms

Andropogon gerardi (2)
Bacteria (2)
Botrytis cinerea (2)
Canis lupus familiaris (2)
Clostridium perfringens (2)
Cnidaria (2)
Cricetulus griseus (2)
Eukaryota (2)
Fasciola (2)
Hepatitis B virus (2)
Human betaherpesvirus 5 (2)
Japanese encephalitis virus group (2)
Madurella mycetomatis (2)
Mesocricetus auratus (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Panicum virgatum (2)
Platyhelminthes (2)
Pseudomonas aeruginosa AES-1R (2)
Rickettsia (2)
Saccharomyces cerevisiae (2)
Schizosaccharomyces pombe (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Sorghastrum nutans (2)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (2)
Streptococcus pneumoniae (2)
Streptomyces coelicolor A3(2) (2)
Toxoplasma gondii (2)
Homo sapiens (1)

Repository

pride (2)
PanoramaPublic (1)

Tissue

Anal canal (1)
Colon (1)
Epithelial cell (1)
Ileum (1)

Disease

Anal canal cancer (1)
Crohn's disease (1)

Technology Type

Mass Spectrometry (2)
Shotgun proteomics (2)

Publication Date

2020 (1)
2019 (1)
2016 (1)

Lab affiliation

Head of Department (Pathology), University of Liege, Liege, Belgium (1)
Laboratory of Translational Gastroenterology, GIGA-institute, University of Liège, 4000 Liège, Belgium Hepato-Gastroenterology and Digestive Oncology Department, Liège University Hospital CHU, 4000 Liège, Belgium (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Anal Canal Cancer : subclassification

Etiologically linked to HPV infection, malignancies of the anal canal have substantially increased in incidence over the last 20 years. Although most anal squamous cell carcinomas (SCC) respond well to chemoradiotherapy, for undetermined reasons, a subgroup of patients experience a poor outcome. Des...

ORGANISM(S): Homo sapiens (Human)

2016-12-20 | PXD004859 | Pride

Discovery of biomarker candidates associated with the risk of short- and long-term relapse after infliximab withdrawal in Crohn’s patients: a proteomics-based study

Objective: A subset of Crohn’s disease (CD) patients experiences long-term remission after infliximab withdrawal. Biomarkers are needed to identify those patients. Design: New biomarkers of relapse were searched in the baseline serum of CD patients stopping infliximab when they were under combined t...

ORGANISM(S): Homo Sapiens

2020-11-02 | PXD019434 | panorama

Common and distinct pathophysiological processes associated to ileal and colonic ulcers in Crohn’s disease

Based on genetic risk factors and natural history, Crohn’s disease (CD) can be separated in two entities, an ileal and a colonic disease. Protein based-approaches are needed to elucidate whether such subphenotypes are related to distinct pathophysiological processes. In this work, we compared the pr...